North Carolina is a leading place for biotech, and a big part of that success comes from GlaxoSmithKline (GSK). This global ...

Dr. Ernest Mario, the founding chair of the Duke University Health System Board of Directors and a leader in the ...

In 2023, the market is anticipated to be valued at USD 26.64 Billion, marking a significant starting point for a decade-long ...

The Industry is on the brink of a substantial surge, with the market size expected to reach USD 100 Million in 2023 and ...

SBI Securities has recommended buying shares of Coal India, Macrotech Developers, Bharti Hexacom, Nippon Life India, Escorts ...

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...

A spokesperson for 23andMe would not comment to NPR on what will happen to genetic data, except to express the company’s ...

Exclusive: One in three researchers say their peers force them to carry out tests with animals if their work is to be ...